(Q44762884)

6 December 2017

title

Transcription factor decoy for AP-1 reduces mesangial cell proliferation and extracellular matrix production in vitro and in vivo (English)

1 reference

6 December 2017

0 references

1 reference

13

1 reference

6 December 2017

Ahn JD

1

1 reference

6 December 2017

Morishita R

2

1 reference

6 December 2017

Kaneda Y

3

1 reference

6 December 2017

Kim HJ

4

1 reference

6 December 2017

Kim YD

5

1 reference

6 December 2017

Lee HJ

6

1 reference

6 December 2017

Lee KU

7

1 reference

6 December 2017

Park JY

8

1 reference

6 December 2017

Kim YH

9

1 reference

6 December 2017

Park KK

10

1 reference

6 December 2017

Chang YC

11

1 reference

6 December 2017

Yoon KH

12

1 reference

6 December 2017

Park KG

14

1 reference

6 December 2017

Lee IK

15

1 reference

6 December 2017

publication date

1 June 2004

1 reference

6 December 2017

1 reference

6 December 2017

volume

11

1 reference

6 December 2017

issue

11

1 reference

6 December 2017

page(s)

916-923

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302236

6 December 2017

exact match

0 references

cites work

Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302236

The progression of renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302236

High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302236

The regulation of AP-1 activity by mitogen-activated protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302236

Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302236

Diverse functions of JNK signaling and c-Jun in stress response and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302236

Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302236

Regulation of gene expression with double-stranded phosphorothioate oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302236

In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302236

Transcription factor decoy for activator protein-1 (AP-1) inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor (PAI-1) gene expression in cultured human vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302236

Inhibitory effects of novel AP-1 decoy oligodeoxynucleotides on vascular smooth muscle cell proliferation in vitro and neointimal formation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302236

Transcription factor decoy for NFkappaB inhibits TNF-alpha-induced cytokine and adhesion molecule expression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302236

Inhibition of mesangial cell proliferation by E2F decoy oligodeoxynucleotide in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302236

Role of AP-1 complex in angiotensin II-mediated transforming growth factor-beta expression and growth of smooth muscle cells: using decoy approach against AP-1 binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302236

Novel E2F decoy oligodeoxynucleotides inhibit in vitro vascular smooth muscle cell proliferation and in vivo neointimal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302236

Role of angiotensin II in diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302236

7 January 2021

Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302236

7 January 2021

NFkappaB decoy oligodeoxynucleotides reduce monocyte infiltration in renal allografts.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302236

7 January 2021

Role of laminin-1, collagen IV, and an autocrine factor(s) in regulated secretion by lacrimal acinar cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302236

7 January 2021

Therapy with antisense TGF-beta1 oligodeoxynucleotides reduces kidney weight and matrix mRNAs in diabetic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302236

7 January 2021

Tissue factor, plasminogen activator inhibitor-1, and thrombin receptor expression in human crescentic glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302236

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302236

1 reference

6 December 2017

1 reference